Job Recruitment Website - Property management - Which leading stocks are there in medical stocks (at a glance)

Which leading stocks are there in medical stocks (at a glance)

Which leading stocks are there in medical stocks (at a glance)

Medical concept stocks include 98 listed companies such as Mindray Medical, Aier Ophthalmology, Wan Tai Bio, Aimeike, Tiger Medicine, Huada Zhizao, Lepu Medical, New Industry, Tongce Medical and Antu Bio. Which are the leading medical units? The following small series brings leading medical stocks, which is of great benefit to you. Let's have a look.

What are the leading stocks in medical stocks?

1, Zheng Guang ophthalmology, stock code: 002524.

As a leading medical service stock, the latest price today is 6.9 1 yuan, the turnover rate is 0.0727%, the dynamic P/E ratio is -27.96, and the P/B ratio is 12. 14.

2. Maipu Medicine, stock code: 30 1033.

As a leading medical service stock, the latest price today is 38.9 1 yuan, the turnover rate is 0.0224%, the dynamic P/E ratio is 60.5 1, and the P/B ratio is 4.38.

3. Jiahe Kangmei, stock code: 688246.

As a leading medical service stock, the latest price today is 22.28 yuan, the turnover rate is 0.0094%, the dynamic P/E ratio is -59.5, and the P/B ratio is 1.8.

4. Aoyang Health, stock code: 002 172.

The leading stock of medical services, the latest price today is 3.6 1 yuan, the turnover rate is 0.0088%, the dynamic P/E ratio is 30.45, and the P/B ratio is 25.67.

5. Baihua Medicine, stock code: 60072 1.

As a leading medical service stock, the latest price today is 5.89 yuan, the turnover rate is 0.0034%, the dynamic P/E ratio is 107.32, and the P/B ratio is 3. 19.

6. Huasu Holdings, stock code: 00509

As a leading medical service stock, the latest price today is 3.67 yuan, the turnover rate is 0.0022%, the dynamic P/E ratio is 304.58, and the P/B ratio is 27.23.

7. Da Wei Jiakang, stock code: 30 1 126.

As a leading medical service stock, the latest price today is 15. 15 yuan, with a turnover rate of 0.0229%, a dynamic P/E ratio of 40.94 and a P/B ratio of 1.83.

8. South China Biology, stock code: 000504.

As a leading medical service stock, the latest price today is 12.93 yuan, the turnover rate is 0.0038%, the dynamic P/E ratio is 929.58, and the P/B ratio is 2 14.2 1.

9. Nuohe Zhiyuan, stock code: 6883 15.

As a leading medical service stock, the latest price today is 27.57 yuan, the turnover rate is 0.0065%, the dynamic P/E ratio is 97.3, and the P/B ratio is 6.

10, Meinian Health, stock code: 002044

As a leading medical service stock, the latest price today is 4.37 yuan, the turnover rate is 0.0042%, the dynamic P/E ratio is-12.83, and the P/B ratio is 2.35.

What are the leading stocks in medical stocks?

1. zhifei Bio:

_ _ _ Miao agent sales manager, stock code (300 122)

Highlights of the company: China is the most comprehensive private biological seedling supplier and service provider.

Main business: R&D, production and sales of seedlings and biological products.

2. General medical care:

Dental medical faucet, stock code (600763)

Highlights of the company: leading oral medical platform vendors and service providers.

3. Lepu Medical:

Leader of cardiac stent system, stock code (300003)

Highlights of the company: the leading cardiovascular equipment in China

Main business: technical development, production and sales of medical devices and their accessories.

4. Marine creatures:

Disposable hemoperfusion faucet, stock code (300529)

Highlights of the company: a professional provider of comprehensive solutions for blood purification.

Main business: R&D, producing and selling hemoperfusion related products.

5. Dabo Medical:

Orthopedic faucet, stock code (00290 1)

Company highlights: one of the leading enterprises in the field of orthopedic implant medical consumables in China.

Main business: production, research and development and sales of high-value medical consumables.

6. Mindray Medical:

Leading medical devices, stock code (300760)

Highlights of the company: domestic medical equipment leader

Main business: research and development, manufacturing, marketing and service of medical devices. Top 6, stop

7. My martial arts creature:

Desensitization drug faucet, stock code (300357)

Highlights of the company: the only company in China that produces standardized sublingual desensitization drugs.

Main business: R&D, producing and selling allergen products.

8. Changchun High-tech:

Innovative pharmaceutical growth hormone leader, stock code (00066 1)

Highlights of the company: the leading products, growth hormone series products and freeze-dried live attenuated varicella vaccine, have obvious market advantages.

Main business: biopharmaceuticals, production and sales of Chinese patent medicines and real estate development are the leading industries, supplemented by infrastructure construction and property management in development zones.

9. Aier Ophthalmology:

Ophthalmology medical leader, stock code (3000 15)

Highlights of the company: One of the largest ophthalmic medical institutions in China, a leading chain enterprise of private ophthalmic hospitals.

Main business: ophthalmology medical service and optometry medical service.

List of medical leading stocks

Longtou 1, Yangpu Medical: The company is engaged in diagnostic products in medical laboratories.

Leading 2, Sanxin Medical: The company's main business is disposable medical devices.

Bibcock 3, Jingwei Hui Kai: The company is engaged in LCD and touch screen modules, electromagnetic wires and reactors.

Leading 4, Mindray Medical: The company's business includes medical devices.

Recent situation of pharmaceutical stock leaders

Yangpu medical treatment: the protagonist

In the past five trading days, the stock price rose by 2.05%, with the highest price of 7.38 yuan, the total market value increased by 4,637,438+0,000, and the current market value was 2.288 billion yuan. 165438+1October 9, the main stock net outflow 14 18600 yuan, the large single stock net outflow 14 18600 yuan, the single stock net inflow of 2,928,400 yuan.

Sanxin Medical: Leading

In the past five trading days, Sanxin Medical rose by 1.86% as a whole, with the highest price of 9.22 yuan and the lowest price of 8.84 yuan, and the total market value increased by 67.5537 million yuan. 165438+1October 9 news, the net inflow of main funds of Sanxin Medical was 2,739,300 yuan, and the net inflow of retail funds was 445,600 yuan.

Jingwei Hui Kai: the dragon head

In the past five days, the share price of Jingwei Hui Kai fell by 0.29%, and the total market value fell by 9.288 million. The current market value is 310.90 billion yuan. In 2022, the stock price fell by -34.4%. 165438+1October 9 news, Jingwei Hui Kai165438+1October 9, the main net inflow was 2.23 million yuan, the large single net inflow was 2.23 million yuan, and the retail outlet was 1008600 yuan.

Mindray Medical: Leading

The stock price fell by 5.36% in the last five days and-1 1.54% in 2022. 1October 9 165438+ The net outflow of main funds, super-large single funds, large single funds, 65438+68 million yuan, single funds116/kloc-0.

Yangpu Medical Treatment (300030)

The financial report shows that in the third quarter of 2022, the company's operating income was 65438+77 million yuan; The net profit attributable to listed shareholders is-265,438+0,836, 600 yuan; Fully diluted net assets income-2.32%; Gross profit margin is 36.76%, and earnings per share is -0.07 yuan.

Sanxin Medical Treatment (300453)

Sanxin Medical released its financial report for the third quarter of 2022, achieving an operating income of 324 million yuan, a year-on-year increase of 2. 17%, and a net profit of 37.7908 million yuan, a year-on-year increase of-12.79%; Earnings per share is 0. 1 yuan.

Jingwei Hui Kai (300 120)

Jingwei Hui Kai released its financial report for the third quarter of 2022, achieving an operating income of 86 1 billion yuan, a year-on-year increase of-1.62%, and a net profit of 20,774,900 yuan, a year-on-year increase of-7.86%; Earnings per share is 0.04 yuan.

Mindray Medical Treatment (300760)

Mindray Medical released its financial report for the third quarter of 2022, achieving an operating income of 7.94 billion yuan, a year-on-year increase of 20.07%, and a net profit of 28/kloc-0.50 billion yuan, a year-on-year increase of 2/kloc-0.4%; Earnings per share is 2.33 yuan.